Werewolf Therapeutics, Inc. (Nasdaq: HOWL) (the 'Company” or 'Werewolf”), an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune ...

NEWARK, CA / ACCESS Newswire / February 24, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") ...

In 2024, the FDA granted 510(k) clearance to a hemodialysis machine capable of delivering online high-volume hemodiafiltration. Since then, companies have started phased introduction of the system ...

Abstract: Next-generation sequencing (NGS) genomic data offer valuable high-throughput genomic information for computational applications in medicine. Using genomic data to identify disease-associated ...

A small but mighty piece of lab equipment, about the size of a cellphone, has arrived at the International Space Station ...

According to a Reuters report on February 18, Australia’s CSL said it had granted Eli Lilly and Company (NYSE:LLY) certain ...

Chronic pain lasts longer for women than men, and new research suggests differences in hormone-regulated immune cells, called ...

Women are more likely to experience chronic pain, studies have found, and their pain lasts longer, on average. New research ...

Researchers hope the findings could lead to non‑opioid pain relief and help ensure that women’s pain is taken seriously.

A small but mighty piece of lab equipment, about the size of a cellphone, has arrived at the International Space Station ...

Abstract: The detection of cytokines, which are key proteins involved in immune system signaling, is of extreme importance for health monitoring. Among the various cytokines, interleukin-6 (IL-6) is ...